机构：[1]Department of Cell Biology & Institute of Biomedicine, MOE Key Laboratory of Tumor Molecular Biology, Guangdong Provincial Key Laboratory of Bioengineering Medicine, National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, Guangzhou 510632, China.[2]Department of Thoracic Surgery, The First Affiliated Hospital of Jinan University, Guangzhou 510632, China.[3]State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau 519000, China.
The process of protein ubiquitination and deubiquitination plays an important role in maintaining protein stability and regulating signal pathways, and protein homeostasis perturbations may induce a variety of diseases. The deubiquitination process removes ubiquitin molecules from the protein, which requires the participation of deubiquitinating enzymes (DUBs). Ubiquitin-specific protease 15 (USP15) is a DUB that participates in many biological cell processes and regulates tumorigenesis. A dislocation catalytic triplet was observed in the USP15 structure, a conformation not observed in other USPs, except USP7, which makes USP15 appear to be unique. USP15 has been reported to be involved in the regulation of various cancers and diseases, and the reported substrate functions of USP15 are conflicting, suggesting that USP15 may act as both an oncogene and a tumor suppressor in different contexts. The importance and complexity of USP15 in the pathological processes remains unclear. Therefore, we reviewed the diverse biological functions of USP15 in cancers and other diseases, suggesting the potential of USP15 as an attractive therapeutic target.
基金：
National Key Research and Development Program of
China No. 2017YFA0505104 (ZS), the National Natural Science Foundation of China Nos. 81772540
(ZS) and 51922111 (MWC), the Science and Technology Program of Guangdong No. 2019A050510023
(ZS) and the Science and Technology Development Fund, Macau SAR No. 0124/2019/A3 (MWC).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2021]版：
大类|3 区工程技术
小类|3 区生化与分子生物学3 区医学：研究与实验3 区药学
最新[2025]版：
大类|3 区医学
小类|3 区生化与分子生物学3 区医学：研究与实验3 区药学
第一作者：
第一作者机构：[1]Department of Cell Biology & Institute of Biomedicine, MOE Key Laboratory of Tumor Molecular Biology, Guangdong Provincial Key Laboratory of Bioengineering Medicine, National Engineering Research Center of Genetic Medicine, College of Life Science and Technology, Jinan University, Guangzhou 510632, China.
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Li Yan-Chi,Cai Song-Wang,Shu Yu-Bin,et al.USP15 in Cancer and Other Diseases: From Diverse Functionsto Therapeutic Targets.[J].Biomedicines.2022,10(2):doi:10.3390/biomedicines10020474.
APA：
Li Yan-Chi,Cai Song-Wang,Shu Yu-Bin,Chen Mei-Wan&Shi Zhi.(2022).USP15 in Cancer and Other Diseases: From Diverse Functionsto Therapeutic Targets..Biomedicines,10,(2)
MLA：
Li Yan-Chi,et al."USP15 in Cancer and Other Diseases: From Diverse Functionsto Therapeutic Targets.".Biomedicines 10..2(2022)
